human cervix carcinoma cell line hela Search Results


human cervix carcinoma hela cell lines  (Corning Life Sciences)
90
Corning Life Sciences human cervix carcinoma hela cell lines
Histological analysis of nsPEF treated tumors. 30–50 mm <t>3</t> <t>B16F10</t> tumors were treated with 750, 200-ns pulses (25 kV/cm, 2 Hz) or left untreated (sham control). Panel A shows H&E pictures for one sham and one nsPEF-treated tumor collected at 4 h post treatment. In ( B ), both anti-cleaved caspase 3 (green) and -Ki-67 (red) immunofluorescence were performed to assess apoptosis and cell proliferation, respectively. Panel B shows representative images from three sham (top) and three nsPEF (bottom) -treated tumors. Panel C shows a positive control for the anti-cleaved Caspase 3 staining, namely <t>HeLa</t> cells treated with 1 μm staurosporin for 5 h. Scale bar: 1000 μm or 100 μm (inset) ( A ); 100 μm ( B , C ).
Human Cervix Carcinoma Hela Cell Lines, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cervix+carcinoma+cell+line+hela/human+cervix+carcinoma+hela+cell+lines/pmc06344591-237-7-21
Average 90 stars, based on 1 article reviews
human cervix carcinoma hela cell lines - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
hela cells no. 93021013 human negroid cervix epitheloid carcinoma cell line  (European Collection of Authenticated Cell Cultures)
90
European Collection of Authenticated Cell Cultures hela cells no. 93021013 human negroid cervix epitheloid carcinoma cell line
Effect of siRNA against Mcl-1 on etoposide cytotoxicity in different cell lines. (Panel a ): The cells were transfected (6 h) with siRNA against Mcl-1 or negative control. Cells were then treated with 60 μM etoposide 24 h post transfection and incubation continued until experiment was ended. The proliferation was calculated from doubling time value as explained in Materials and methods section. Each bar represents mean ± s.d. of at least three independent experiments (N <t>HeLa</t> = 4, N Hep G2 = 3, N Caco-2 = 3), in each experiment triplicate measurements were performed. **p < 0.01 versus corresponding negative control. (Panel b ): Evaluation of siRNA efficiency by western blot analysis in <t>Hela</t> <t>cells.</t> The cells were transfected (6 h) with anti-Mcl-1 siRNA or negative control. Shown are representative western blots of cells cultured for 24 h after transfection. (Panel c ): Evaluation of siRNA efficiency by western blot analysis in Hep G2 cells. Treatment was the same as for panel b. Panel d: Evaluation of siRNA efficiency by western blot analysis in Caco-2 cells. Treatment was the same as for (panel b ).
Hela Cells No. 93021013 Human Negroid Cervix Epitheloid Carcinoma Cell Line, supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cervix+carcinoma+cell+line+hela/hela+cells+no++93021013+human+negroid+cervix+epitheloid+carcinoma+cell+line/pmc11349908-168-0-6
Average 90 stars, based on 1 article reviews
hela cells no. 93021013 human negroid cervix epitheloid carcinoma cell line - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
hela human cervix epitheloid carcinoma ecacc 93021013  (European Collection of Authenticated Cell Cultures)
90
European Collection of Authenticated Cell Cultures hela human cervix epitheloid carcinoma ecacc 93021013
Effect of siRNA against Mcl-1 on etoposide cytotoxicity in different cell lines. (Panel a ): The cells were transfected (6 h) with siRNA against Mcl-1 or negative control. Cells were then treated with 60 μM etoposide 24 h post transfection and incubation continued until experiment was ended. The proliferation was calculated from doubling time value as explained in Materials and methods section. Each bar represents mean ± s.d. of at least three independent experiments (N <t>HeLa</t> = 4, N Hep G2 = 3, N Caco-2 = 3), in each experiment triplicate measurements were performed. **p < 0.01 versus corresponding negative control. (Panel b ): Evaluation of siRNA efficiency by western blot analysis in <t>Hela</t> <t>cells.</t> The cells were transfected (6 h) with anti-Mcl-1 siRNA or negative control. Shown are representative western blots of cells cultured for 24 h after transfection. (Panel c ): Evaluation of siRNA efficiency by western blot analysis in Hep G2 cells. Treatment was the same as for panel b. Panel d: Evaluation of siRNA efficiency by western blot analysis in Caco-2 cells. Treatment was the same as for (panel b ).
Hela Human Cervix Epitheloid Carcinoma Ecacc 93021013, supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cervix+carcinoma+cell+line+hela/hela++human+cervix+epitheloid+carcinoma++ecacc+93021013+/pmc10074951-249-0-10
Average 90 stars, based on 1 article reviews
hela human cervix epitheloid carcinoma ecacc 93021013 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
human cervix carcinoma hela  (European Collection of Authenticated Cell Cultures)
90
European Collection of Authenticated Cell Cultures human cervix carcinoma hela
Effect of siRNA against Mcl-1 on etoposide cytotoxicity in different cell lines. (Panel a ): The cells were transfected (6 h) with siRNA against Mcl-1 or negative control. Cells were then treated with 60 μM etoposide 24 h post transfection and incubation continued until experiment was ended. The proliferation was calculated from doubling time value as explained in Materials and methods section. Each bar represents mean ± s.d. of at least three independent experiments (N <t>HeLa</t> = 4, N Hep G2 = 3, N Caco-2 = 3), in each experiment triplicate measurements were performed. **p < 0.01 versus corresponding negative control. (Panel b ): Evaluation of siRNA efficiency by western blot analysis in <t>Hela</t> <t>cells.</t> The cells were transfected (6 h) with anti-Mcl-1 siRNA or negative control. Shown are representative western blots of cells cultured for 24 h after transfection. (Panel c ): Evaluation of siRNA efficiency by western blot analysis in Hep G2 cells. Treatment was the same as for panel b. Panel d: Evaluation of siRNA efficiency by western blot analysis in Caco-2 cells. Treatment was the same as for (panel b ).
Human Cervix Carcinoma Hela, supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cervix+carcinoma+cell+line+hela/human+cervix+carcinoma+hela/pm37445759-295-13-34
Average 90 stars, based on 1 article reviews
human cervix carcinoma hela - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
human negroid cervix carcinoma hep2 cell line  (KAC Co Ltd)
90
KAC Co Ltd human negroid cervix carcinoma hep2 cell line
Effect of siRNA against Mcl-1 on etoposide cytotoxicity in different cell lines. (Panel a ): The cells were transfected (6 h) with siRNA against Mcl-1 or negative control. Cells were then treated with 60 μM etoposide 24 h post transfection and incubation continued until experiment was ended. The proliferation was calculated from doubling time value as explained in Materials and methods section. Each bar represents mean ± s.d. of at least three independent experiments (N <t>HeLa</t> = 4, N Hep G2 = 3, N Caco-2 = 3), in each experiment triplicate measurements were performed. **p < 0.01 versus corresponding negative control. (Panel b ): Evaluation of siRNA efficiency by western blot analysis in <t>Hela</t> <t>cells.</t> The cells were transfected (6 h) with anti-Mcl-1 siRNA or negative control. Shown are representative western blots of cells cultured for 24 h after transfection. (Panel c ): Evaluation of siRNA efficiency by western blot analysis in Hep G2 cells. Treatment was the same as for panel b. Panel d: Evaluation of siRNA efficiency by western blot analysis in Caco-2 cells. Treatment was the same as for (panel b ).
Human Negroid Cervix Carcinoma Hep2 Cell Line, supplied by KAC Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cervix+carcinoma+cell+line+hela/human+negroid+cervix+carcinoma+hep2+cell+line/pm36201881-65-8-19
Average 90 stars, based on 1 article reviews
human negroid cervix carcinoma hep2 cell line - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Histological analysis of nsPEF treated tumors. 30–50 mm 3 B16F10 tumors were treated with 750, 200-ns pulses (25 kV/cm, 2 Hz) or left untreated (sham control). Panel A shows H&E pictures for one sham and one nsPEF-treated tumor collected at 4 h post treatment. In ( B ), both anti-cleaved caspase 3 (green) and -Ki-67 (red) immunofluorescence were performed to assess apoptosis and cell proliferation, respectively. Panel B shows representative images from three sham (top) and three nsPEF (bottom) -treated tumors. Panel C shows a positive control for the anti-cleaved Caspase 3 staining, namely HeLa cells treated with 1 μm staurosporin for 5 h. Scale bar: 1000 μm or 100 μm (inset) ( A ); 100 μm ( B , C ).

Journal: Scientific Reports

Article Title: Mechanisms and immunogenicity of nsPEF-induced cell death in B16F10 melanoma tumors

doi: 10.1038/s41598-018-36527-5

Figure Lengend Snippet: Histological analysis of nsPEF treated tumors. 30–50 mm 3 B16F10 tumors were treated with 750, 200-ns pulses (25 kV/cm, 2 Hz) or left untreated (sham control). Panel A shows H&E pictures for one sham and one nsPEF-treated tumor collected at 4 h post treatment. In ( B ), both anti-cleaved caspase 3 (green) and -Ki-67 (red) immunofluorescence were performed to assess apoptosis and cell proliferation, respectively. Panel B shows representative images from three sham (top) and three nsPEF (bottom) -treated tumors. Panel C shows a positive control for the anti-cleaved Caspase 3 staining, namely HeLa cells treated with 1 μm staurosporin for 5 h. Scale bar: 1000 μm or 100 μm (inset) ( A ); 100 μm ( B , C ).

Article Snippet: Mouse melanoma B16F10 (ATCC, Manassas, Virginia) and human cervix carcinoma HeLa cell lines were cultured in Dulbecco’s Modified Eagle Medium (DMEM, Corning®, Corning, NY) while the human lymphoma U-937 cell line was cultured in RPMI 1640 (Corning®).

Techniques: Immunofluorescence, Positive Control, Staining

Effect of siRNA against Mcl-1 on etoposide cytotoxicity in different cell lines. (Panel a ): The cells were transfected (6 h) with siRNA against Mcl-1 or negative control. Cells were then treated with 60 μM etoposide 24 h post transfection and incubation continued until experiment was ended. The proliferation was calculated from doubling time value as explained in Materials and methods section. Each bar represents mean ± s.d. of at least three independent experiments (N HeLa = 4, N Hep G2 = 3, N Caco-2 = 3), in each experiment triplicate measurements were performed. **p < 0.01 versus corresponding negative control. (Panel b ): Evaluation of siRNA efficiency by western blot analysis in Hela cells. The cells were transfected (6 h) with anti-Mcl-1 siRNA or negative control. Shown are representative western blots of cells cultured for 24 h after transfection. (Panel c ): Evaluation of siRNA efficiency by western blot analysis in Hep G2 cells. Treatment was the same as for panel b. Panel d: Evaluation of siRNA efficiency by western blot analysis in Caco-2 cells. Treatment was the same as for (panel b ).

Journal: Scientific Reports

Article Title: On the mechanism of miR-29b enhancement of etoposide toxicity in vitro

doi: 10.1038/s41598-024-70856-y

Figure Lengend Snippet: Effect of siRNA against Mcl-1 on etoposide cytotoxicity in different cell lines. (Panel a ): The cells were transfected (6 h) with siRNA against Mcl-1 or negative control. Cells were then treated with 60 μM etoposide 24 h post transfection and incubation continued until experiment was ended. The proliferation was calculated from doubling time value as explained in Materials and methods section. Each bar represents mean ± s.d. of at least three independent experiments (N HeLa = 4, N Hep G2 = 3, N Caco-2 = 3), in each experiment triplicate measurements were performed. **p < 0.01 versus corresponding negative control. (Panel b ): Evaluation of siRNA efficiency by western blot analysis in Hela cells. The cells were transfected (6 h) with anti-Mcl-1 siRNA or negative control. Shown are representative western blots of cells cultured for 24 h after transfection. (Panel c ): Evaluation of siRNA efficiency by western blot analysis in Hep G2 cells. Treatment was the same as for panel b. Panel d: Evaluation of siRNA efficiency by western blot analysis in Caco-2 cells. Treatment was the same as for (panel b ).

Article Snippet: HeLa cells were obtained from The European Collection of Authenticated Cell Cultures (ECACC, No. 93021013 Human Negroid cervix epitheloid carcinoma cell line) via Sigma-Aldrich as provider.

Techniques: Transfection, Negative Control, Incubation, Western Blot, Cell Culture